Edition:
United Kingdom

People: Regeneron Pharmaceuticals Inc (REGN.OQ)

REGN.OQ on NASDAQ Stock Exchange Global Select Market

333.55USD
7:58pm BST
Change (% chg)

$4.51 (+1.37%)
Prev Close
$329.04
Open
$330.05
Day's High
$334.52
Day's Low
$326.90
Volume
121,541
Avg. Vol
324,066
52-wk High
$543.50
52-wk Low
$281.89

Stahl, Neil 

Dr. Neil Stahl, Ph.D., is Executive Vice President - Research and Development Sciences of the Company. He previously served as Senior Vice President, Research and Development Sciences from January 2007 to December 2014, as Senior Vice President, Preclinical Development and Biomolecular Sciences from December 2000 to December 2007, and as Vice President, Preclinical Development and Biomolecular Sciences from January 2000 to December 2000. He joined the Company in 1991. Before becoming Vice President, Biomolecular Sciences in July 1997, Dr. Stahl was Director, Cytokines and Signal Transduction. Dr. Stahl received his Ph.D. in Biochemistry from Brandeis University.

Basic Compensation

Total Annual Compensation, USD 619,300
Restricted Stock Award, USD --
Long-Term Incentive Plans, USD --
All Other, USD 10,366,100
Fiscal Year Total, USD 10,985,400

Options Compensation

  Quantity Market Value
Exercisable 225,000 1,370,450.00
Unexercisable 358,332 2,099,320.00
Exercised 195,079 70,183,600.00
Name Fiscal Year Total

P. Roy Vagelos

13,240,600

Leonard Schleifer

28,337,500

Robert Landry

5,164,730

Daniel Van Plew

2,188,990

Neil Stahl

10,985,400

Joseph LaRosa

--
As Of  31 Dec 2016